Clinicians
Close Clinicians
Open Clinicians
Products
Oncology
Rare Diseases & Reproductive Health
Tools & Resources
Genetic Counselor Consult
Clinical Practice Resources
Variant Classification
Industry & Academia
Close Industry & Academia
Open Industry & Academia
Multiomics Services
DNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Amplicon Sequencing
ChIP Sequencing
RNA Sequencing
Total RNA-Sequencing
mRNA Sequencing
Small RNA Sequencing
Spatial Transcriptomics
Single-Cell RNA Sequencing
Epigenomics
Methylation Sequencing
Targeted Methylation
Methylation Array
Microbial Sequencing
WGM (Shotgun metagenomics)
16S rRNA
Microarray Sequencing
Infinium Genotyping
Genome Wide Association Studies (GWAS)
Methylation Assays
Agrigenomics Consortium Arrays
Integrated Multiomics
Genomic Wellness
Knowledge Hub
Close Knowledge Hub
Open Knowledge Hub
Knowledge Hub
Webinars
Articles
Publication
Posters
Case Studies
White Papers
Media
About Us
Close About Us
Open About Us
Our Story
Our Journey
Our People
Our Facility
Our Careers
Contact Us
PDL-1 SP263 (Ventana)
Test Code
SLS810006
Book Now
What is PDL-1 SP263 (Ventana)?
This test assesses PDL-1 expression using the SP263 clone for guiding immunotherapy with Tecentriq (Atezolizumab) and Imfinzi (durvalumab)
Markers Covered
PDL-1 SP263
Applicable Cancers
NSCLC, Head and Neck
Cancer
, Bladder
Cancer
Technical Information
Methodology
:
IHC
Sample Requirement
Sample Type
:
FFPE
Container
:
Plastic container
Shipping Conditions
:
Ambient (15-22 ⁰C)
Max Transit Time
:
5-6 Days
TAT
5 Days
Contact Us
Name
Email
Phone
Get in Touch
Patient
Doctor
Name
Mobile
Email
City
Referring Clinician
Referring Hospital
Submit
Name
Mobile
Email
City
Speciality
Hospital
Submit
Search
